Causes of Death and Comorbidities in Adult Patients With Late‐Onset Pompe Disease: A French Pompe Registry Retrospective Study
European Journal of Neurology · 2025
DOI: 10.1111/ene.70394 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Neurology, 2025. Verfasst von Diana Maria Chitimus und 26 weiteren Autor:innen. Beteiligte Einrichtung: Raymond Poincaré University Hospital, APHP, Garches, France. Hauptthemen laut MEDLINE: Cause of Death, Glycogen Storage Disease Type II. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Sanofi Genzyme.
Abstract (Originalsprache)
Background and Objectives Mortality in Late‐Onset Pompe Disease (LOPD) has been associated with the rapid progression of respiratory and motor impairment. However, an in‐depth approach to the exact causes of death in these patients is still lacking.
Methods
In this retrospective cohort study, we analyzed the cause of death and the comorbidities of all deceased patients from the French Late‐Onset Pompe Disease registry.
Results
By the time of the last extraction, 60 patients diagnosed with LOPD and monitored were registered as deceased in the French national registry, out of a total of 260 patients included. The median age of death was 70.5 years, while the median age of diagnosis was 58 years. The causes of death were divided into disease‐related, accounting for 46.6% of deaths, and non‐disease‐related, comprising 28.3% of total deaths. Fifteen patients (25%) died of an unknown cause. The most frequent etiology of disease‐related death was respiratory failure ( n = 14), while for the non‐disease‐related group, malignant neoplasm was the most common ( n = 8). Patients in the non‐disease‐related death group had significantly higher forced vital capacity (FVC) values compared to those in the disease‐related death group (54.7% vs. 38%). Treatment‐wise, the median period elapsed from diagnosis to ERT introduction was higher in the disease‐related group.
Discussion
This is the first study to focus on the specific causes of death of LOPD patients. The majority of the LOPD deaths in the French registry were attributed to respiratory failure and malignant neoplasms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Raymond Poincaré University Hospital, APHP, Garches, France.
- INSERM U 1179, Handicap Neuromusculaire, UVSQ Paris-Saclay, Garches, France.
- Doctoral School of Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.
- Nord-Est-Ile-de-France, Neuromuscular Reference Center, FHU PHENIX; Inserm, Paris, France.
- Lille University Hospital Center, Lille, France.
- Neuroscience & Cognition, University of Lille, Lille, France.
ORCID-Profile: Diana Maria Chitimus, Armelle Magot, Sharam Attarian, Dalil Hamroun, Pascal Laforêt
Förderung
- Sanofi Genzyme
Zitieren
APA
Chitimus, D. M., Tard, C., Fournier, M., Bouhour, F., Béhin, A., Salort-Campana, E., Lagrange, E., Kaminsky, A. L., Magot, A., Beltran, S., Noury, J. B., Magy, L., Solé, G., Renard, D., Spinazzi, M., Demurger, F., Cintas, P., Nadaj-Pakleza, A., Deibener-Kaminsky, J., …, & for French Pompe study group (2025). Causes of Death and Comorbidities in Adult Patients With Late‐Onset Pompe Disease: A French Pompe Registry Retrospective Study. European Journal of Neurology. https://doi.org/10.1111/ene.70394
Vancouver
Chitimus DM, Tard C, Fournier M, Bouhour F, Béhin A, Salort-Campana E, et al. Causes of Death and Comorbidities in Adult Patients With Late‐Onset Pompe Disease: A French Pompe Registry Retrospective Study. European Journal of Neurology. 2025. doi:10.1111/ene.70394
BibTeX
@article{Chitimus2025,
author = {Chitimus, Diana Maria and Tard, Céline and Fournier, Maxime and Bouhour, Françoise and Béhin, Anthony and Salort-Campana, Emmanuelle and Lagrange, Emmeline and Kaminsky, Anne-Laure and Magot, Armelle and Beltran, Stéphane and Noury, Jean-Baptiste and Magy, Laurent and Solé, Guilhem and Renard, Dimitri and Spinazzi, Marco and Demurger, Florence and Cintas, Pascal and Nadaj-Pakleza, Aleksandra and Deibener-Kaminsky, Joelle and Bassez, Guillaume and Taouagh, Nadjib and Arrassi, Azzedine and Lefeuvre, Claire and Attarian, Sharam and Hamroun, Dalil and Laforêt, Pascal and for French Pompe study group, for French Pompe study group},
title = {Causes of Death and Comorbidities in Adult Patients With Late‐Onset Pompe Disease: A French Pompe Registry Retrospective Study},
journal = {European Journal of Neurology},
year = {2025},
doi = {10.1111/ene.70394}
}
EUVIMED